Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Conatus Pharmaceuticals Inc. News

Count your blessings; bet on the banks: rev shark's best blog

Rev Shark steps in for Jim Cramer this week.

Futures point north, Asia mixed despite European attacks

Markets look set to continue their election rally as violence casts a pall over Europe.

Here's Why Conatus Pharmaceuticals (CNAT) Stock Is Soaring Today

Conatus Pharmaceuticals (CNAT) stock was boosted on Tuesday after Allergan (AGN) agreed to buy Tobira Therapeutics (TBRA) at a 500% premium.

Conatus Pharmaceuticals (CNAT) Stock Surges, Liver Drug Could Treat Zika

Conatus Pharmaceuticals' (CNAT) patented liver drug emricasan has been identified as a promising treatment for the Zika virus.

Conatus Pharmaceuticals (CNAT) Stock Soars on Positive Liver Drug Trial Results

Conatus Pharmaceuticals (CNAT) stock is increasing in mid-morning trading on Wednesday after the company said a Phase 2 trial of its liver drug showed positive results.

Breaking News

Bank of America Lists Companies With Most Mentions of 'Supply Chain'

These companies made the most mentions of "supply chain" in their first-quarter earnings calls.

Crypto Crisis: Struggling Crypto Lender About to Be Acquired by Rival

Crypto firm Nexo is reviewing the assets of lender Vauld with the intent of acquiring the struggling crypto financial services company.

Ford Makes a Major Change

The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.

Stock Market Today - 7/5: Stocks End Mixed On Recession Fears; Dollar Hits Two-Decade Peak

Stocks bounce back as tech stocks surge as investors focus on growth and inflation prospects in the world's biggest economy.